The status and perspective of the GP-73 in the diagnosis and treatment of hepatocellular carcinoma

VernacularTitle:GP73在肝癌诊断中的研究现状及前景
Author: Song GAO ; Shuzhong CUI ; Mingchen BA
Publication Type:Journal Article
Keywords: Carcinoma hepatocellular; The early period of diagnosis; GP-73
From: Chinese Journal of Hepatobiliary Surgery 2010;16(12):961-963
CountryChina
Language:Chinese
Abstract: Hepatocellular carcinoma(HCC) is one of the most common malignant tumors with the highest cause of death and increasing incidence worldwide, and the annual incidence rate is rising. The early diagnosis of HCC is very essential to its prognosis. At present, AFP has been widely used in the survey of HCC diagnosis, therapeutic effect and predict recurrence. However, the sensitivity and specificity of AFP is not satisfactory. In recent years a variety of new serum tumor markers have emerged one after another. A new serum marker-Golgi glycoprotein-73(GP-73) in early diagnosis of HCC is expected to become the new target maker,its sensitivity and specificity are better than AFP.